Vet Comp Orthop Traumatol 2015; 28(03): 199-206
DOI: 10.3415/VCOT-14-09-0141
Original Research
Schattauer GmbH

Perioperative risk factors for surgical site infection in tibial tuberosity advancement: 224 stifles

F. W. Yap
1   Small Animal Hospital, Faculty of Veterinary Medicine, University of Glasgow, United Kingdom
,
I. Calvo
1   Small Animal Hospital, Faculty of Veterinary Medicine, University of Glasgow, United Kingdom
,
K.D. Smith
1   Small Animal Hospital, Faculty of Veterinary Medicine, University of Glasgow, United Kingdom
,
T. Parkin
1   Small Animal Hospital, Faculty of Veterinary Medicine, University of Glasgow, United Kingdom
› Author Affiliations
Further Information

Publication History

Received: 14 September 2014

Accepted: 12 February 2018

Publication Date:
24 October 2018 (online)

Zoom Image

Summary

Objective: To examine perioperative factors affecting surgical site infection (SSI) rate following tibial tuberosity advancement (TTA).

Study design: Retrospective case series.

Sample population: 224 stifles in 186 dogs.

Methods: Medical records of dogs that underwent TTA in a single institution were reviewed. Information on signalment anaesthetic and surgical parameters, as well as occurrence of SSI was recorded. Dogs were followed for a minimum of three months postoperatively. The association between perioperative factors and SSI was assessed using

Chi-squared tests and binary logistic regression.

Results: The prevalence of SSI was 5.3% (12/224 TTA). Surgical time (p = 0.02) and anaesthesia time (p = 0.03) were significantly associated with SSI. For every minute increase in surgical time and anaesthesia time, the likelihood of developing SSI increased by seven percent and four percent respectively. The use of postoperative antimicrobial therapy was not significantly associated with lower SSI (p = 0.719). Implants were removed in 1.3% of cases (3/224 TTA).

Conclusions: The findings of this study suggest that increased surgical and anaesthesia times are significant risk factors for SSI in TTA, and that there is no evidence that postoperative prophylactic antimicrobial therapy is associated with SSI rate.